Table 2 Pregnancy, childbearing and PKD discussions with health care providers
Discussion topics (‘yes’ responses) | Topics women would like to discuss with their health care providers | Topics women find or think might be difficult to discuss with their health care providers |
|---|---|---|
n (%) | ||
Need to genetic counselling and pre-implantation genetic diagnosis prior to pregnancy (n = 16) | 8 (50.0) | 3 (18.8) |
Getting pregnant (n = 16) | 7 (43.8) | 4 (25.0) |
Baby inheriting PKD (n = 16) | 7 (43.8) | 3 (18.8) |
Impact of pregnancy on PKD (n = 16) | 7 (43.8) | 3 (18.8) |
Impact of PKD on pregnancy (n = 16) | 7 (43.8) | 3 (18.8) |
PKD medications – safe to use during pregnancy (n = 16) | 5 (31.3) | 1 (6.3) |
PKD medications – safe to use while breastfeeding (n = 16) | 5 (31.3) | 1 (6.3) |
OK to breastfeed given PKD (n = 16) | 1 (6.3) | 1 (6.3) |